Neovasc Inc. Depreciation & Amortization Growth

Depreciation & Amortization Growth of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Depreciation & Amortization Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Depreciation & Amortization Growth for the quarter ending March 31, 2022 was -34.46% (a 9.43% increase compared to previous quarter)
  • Year-over-year quarterly Depreciation & Amortization Growth decreased by -1942.78%
  • Annual Depreciation & Amortization Growth for 2021 was -18.35% (a -176.87% decrease from previous year)
  • Annual Depreciation & Amortization Growth for 2020 was 23.87% (a -69.74% decrease from previous year)
  • Annual Depreciation & Amortization Growth for 2019 was 78.89% (a -331.76% decrease from previous year)
  • Twelve month Depreciation & Amortization Growth ending March 31, 2022 was -22.45% (a 62.8% increase compared to previous quarter)
  • Twelve month trailing Depreciation & Amortization Growth decreased by -353.1% year-over-year
Trailing Depreciation & Amortization Growth for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
-22.45% -13.79% -2.71% 8.87%
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Depreciation & Amortization Growth of Neovasc Inc.

Most recent Depreciation & Amortization Growthof NVCN including historical data for past 10 years.

Interactive Chart of Depreciation & Amortization Growth of Neovasc Inc.

Neovasc Inc. Depreciation & Amortization Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -34.46%
2021 -31.49% -24.56% 1.87% 1.81% -18.35%
2020 10.53% 23.56% 25.05% 27.18% 23.87%
2019 86.59% 59.71% 60.02% 60.13% 78.89%
2018 -30.33% -31.18% -30.21% -18.87% -34.04%
2017 -24.23% -33.94% -32.63% -24.54% -26.55%
2016 7.56% 85.91% 86.27% 51.75% 50.03%
2015 63.64% 44.63% 33.88% 38.86% 48.41%
2014 22.22% -11.11% 60.0% 133.33% 30.54%
2013 125.0% 200.0% 25.0% 50.0% 100.0%
2012 -55.56% -66.67% -20.0% -33.33% 44.44%
2011 125.0% -30.77%

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.